Literature DB >> 17320839

Multi-modal characterisation of the neocortical clip model of focal cerebral ischaemia by MRI, behaviour and immunohistochemistry.

Maria Ashioti1, John S Beech, Andrew S Lowe, Mayke B Hesselink, Michael Modo, Steve C R Williams.   

Abstract

The neocortical clip model of focal cerebral ischaemia has previously been used with success in neuroprotection studies. To further improve its translational qualities, we have characterised this model using a combination of serial Magnetic Resonance Imaging (MRI), neurological assessment, the bilateral asymmetry test (BAT) and immunohistochemistry. The right MCA was occluded in spontaneously hypertensive rats for 0, 60 and 120 min. MRI was performed pre-surgery, 1, 3 and 7 days post-surgery. Behavioural assessment was performed 2 days before and 3 and 7 days post-surgery whilst neurological deficits were monitored daily. Neuroimaging results showed that 0 min of MCA occlusion did not produce a lesion, whereas occlusion for 60 min produced a lesion that remained stable over time. Occlusion for 120 min caused a more severe lesion 1 day post-surgery, but decreased by 7 days. Behaviour, neurological scores and histological lesion volumes correlated strongly with MRI lesion volume. Immunohistochemistry revealed neuronal loss, astrogliosis and macrophage infiltration in lesioned cortices. The neocortical clip model produced ischaemic lesions that are restricted to cortical territories of the MCA. The duration of occlusion dictates lesion severity which may prove useful for probing therapeutic interventions at different stages of stroke progression. The correlation of MRI with two different behavioural measures and post-mortem histology strengthens the basis for MRI providing an in vivo surrogate marker for structural and behavioural deficits caused by a cortical stroke.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17320839     DOI: 10.1016/j.brainres.2007.01.111

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  20 in total

1.  A chronic 1 year assessment of MRI contrast agent-labelled neural stem cell transplants in stroke.

Authors:  M Modo; J S Beech; T J Meade; S C R Williams; J Price
Journal:  Neuroimage       Date:  2008-06-25       Impact factor: 6.556

2.  Long-term survival and serial assessment of stroke damage and recovery - practical and methodological considerations.

Authors:  Michel Modo
Journal:  J Exp Stroke Transl Med       Date:  2009-01

3.  Long-term retention of ECM hydrogel after implantation into a sub-acute stroke cavity reduces lesion volume.

Authors:  Harmanvir Ghuman; Madeline Gerwig; Francesca J Nicholls; Jessie R Liu; Julia Donnelly; Stephen F Badylak; Michel Modo
Journal:  Acta Biomater       Date:  2017-09-13       Impact factor: 8.947

4.  Repetitive hypoxia extends endogenous neurovascular protection for stroke.

Authors:  Ann M Stowe; Tamer Altay; Angela B Freie; Jeffrey M Gidday
Journal:  Ann Neurol       Date:  2011-03-17       Impact factor: 10.422

5.  Spatial and temporal MRI profile of ischemic tissue after the acute stages of a permanent mouse model of stroke.

Authors:  A Bogaert-Buchmann; M Poittevin; C Po; D Dupont; C Sebrié; Y Tomita; A Trandinh; J Seylaz; E Pinard; P Méric; N Kubis; B Gillet
Journal:  Open Neuroimag J       Date:  2013-02-01

Review 6.  Use of magnetic resonance imaging to predict outcome after stroke: a review of experimental and clinical evidence.

Authors:  Tracy D Farr; Susanne Wegener
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-20       Impact factor: 6.200

7.  A systematic optimization of 19F MR image acquisition to detect macrophage invasion into an ECM hydrogel implanted in the stroke-damaged brain.

Authors:  Harmanvir Ghuman; T Kevin Hitchens; Michel Modo
Journal:  Neuroimage       Date:  2019-08-10       Impact factor: 6.556

8.  Neither in vivo MRI nor behavioural assessment indicate therapeutic efficacy for a novel 5HT(1A) agonist in rat models of ischaemic stroke.

Authors:  Maria Ashioti; John S Beech; Andrew S Lowe; Michel Bernanos; Andrew McCreary; Michel M Modo; Steve C R Williams
Journal:  BMC Neurosci       Date:  2009-07-16       Impact factor: 3.288

9.  Non-invasive evaluation of nigrostriatal neuropathology in a proteasome inhibitor rodent model of Parkinson's disease.

Authors:  Anthony C Vernon; Saga M Johansson; Michel M Modo
Journal:  BMC Neurosci       Date:  2010-01-05       Impact factor: 3.288

Review 10.  Selective neuronal loss in ischemic stroke and cerebrovascular disease.

Authors:  Jean-Claude Baron; Hiroshi Yamauchi; Masayuki Fujioka; Matthias Endres
Journal:  J Cereb Blood Flow Metab       Date:  2013-11-06       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.